Article information
Full text is only aviable in PDF
BIBLIOGRAFIA GERAL
[1.]
WORLD DRUG REPORT.
United Nations Office for Drug Control and Crime Prevention, (2000),
[2.]
Droga.
Sumários de informação estatística, Institute Português da Droga e da Toxicodependência, (2000),
[3.]
D.P. Tashkin.
Airway effects of Marijuana, cocaine, and other inhaled illicit agents.
Curr Opin Pulm Med, 2 (2001 Mar), pp. 43-61
[4.]
D.P. Taskin, E.C. Kleerup, S. Koyal, et al.
Acute effects of inhaled and intravenous cocaine on airways dynamics.
Chest, 110 (1996), pp. 904-910
[5.]
F. Nistal De Paz, Fernandez J.J. Ordiales, Gonzalez J. Allende, Colubi L. Colubi.
Pulmonary complications related to cocaine consumption.
Ann Med Interna, 6 (1999), pp. 371-379
[6.]
G. Barrio, L. De La Fuente, M.J. Bravo, E. Regidor, F. Rodriguez-Artalejo.
Acute respiratory problems and cocaine or heroine smoking.
Med. Clin. (Bare), 112 (1999), pp. 775-777
[7.]
E.C. Kleerup, M. Wong, J.A. Marques-Magallanes, M.D. Goldman, D.P. Taskin.
Acute effects of intravenous cocaine on pulmonary artery pressure and cardiac index in habitual crack smokers.
Chest, 11181 (1997), pp. 30-35
[8.]
Donald P. Taskin, Maria-Elena Khalsa, David Gorelick, Potter Chang, Michael S. Simmons, Anne H. Coulson, Gong J.R. Henry.
Pulmonary Status of habitual Cocaine Smokers.
Am Rev Resp Dis, 145 (1992), pp. 92-100
[9.]
H. Susskind, D.A. Weber, N.D. Volkow, et al.
Increase lung permeability following long-term use of freebase cocaine (crack).
Chest, 100 (1991), pp. 903-909
[10.]
D.P. Tashkin, E.C. Kleerup, C.K. Hop, K.J. Kim, M.M. Weber, Gile.
Effects of “crack” cocaine on pulmonary alveolar permeability.
Chest, 112 (1997), pp. 327-335
[11.]
J.A. Marques-Magalhães, S.N. Koyal, C.B. Cooper, E.C. Kleerup, D.P. Tashkin.
Impact of habitual cocaine smoking on the physiologic response to maximum exercise.
Chest, 112 (1997), pp. 1008-1016
[12.]
S.H. Barsky, M.D. Roth, E.C. Kleerup, M. Simmons, D.P. Tashkin.
Histopathologic and molecular alterations in bronquial epithelium in habitual smokers of marijuana, cocaine, and/or tobacco.
J Natl Cancer Inst, 90 (1998), pp. 1198-2005
[13.]
S.E. Fligiel, M.D. Roth, E.C. Kleerup, S.H. Barsky, M.S. Simmons, D.P. Tashkin.
Tracheobronquial histopathology in habitual smokers of cocaine, marijuana, and/or tobacco.
Chest, 112 (1997), pp. 319-326
[14.]
M.A.O. Li, O.H. Yun.
Does Marijuana or Crack Cocaine Cause Cancer?.
Journal of National Cancer Institute, 90 (August 19. 1998),
[15.]
M.E. Bailey, A.E. Fraire, S.D. Greenberg, et al.
Pulmonary histophatology in cocaine abusers.
Hum Pathol, 25 (1994), pp. 203-207
[16.]
A. Elizabeth, M.D. Laposata, L. George, B.A. Mayo.
A review of Pulmonary pathology and Mechanisms associated with Inhalation of freebase Cocaine (“crack”).
The American Journal of Forensic medicine and Pathology, 14 (1993), pp. 1-9
[17.]
T.M. Janjua, A.E. Bohan, U. Wesselius.
Increase Lower respiratory tract iron concentration in alkaloidal (crack”) cocaine users.
Chest, 119 (2001), pp. 422-427
[18.]
G.C. Baldwin, D.P. Taskin, D.M. Buckley, A.N. Park, S.M. Dubinett, M.D. Roth.
Marijuana and cocaine impair alveolar macrophages function and cytokine Production.
AM J Crit Care Med, 156 (1997), pp. 1606-1613
[19.]
G.C. Baldwin, M.D. Buckley, D.M. Roth, E.C. Kleeprup, D.P. Tashkin.
Acute activation of circulating polymorph nuclear neutrophils following in vivo administration of cocaine. A potential etiology for pulmonary injury.
Chest, 111 (1997), pp. 698-705
[20.]
Dani Y. Haim MD, Michael L. Lippmann MD, FCCP, Steven K. Goldberg MD, Michael D. Walkenstein MD FCCP.
The pulmonary Complication of Crack Cocaine: a comprehensive review.
Chest, 107 (1995), pp. 233-240
[21.]
Joshua A. Perper, David H. Van Thiel.
Respiratory Complications of cocaine abuse.
[22.]
D.P. Tashkin.
Pulmonary Complications of Smoked Substance Abuse.
West J Med, 152 (1990), pp. 525-530
[23.]
J.M. Forrest, A.W. Steele, J.A. Waldron, P.E. Parson.
Crack lung: an acute pulmonary syndrome with a spectrum of clinical and histopathologic findings.
Am Rev Resp Dis, 142 (1990), pp. 462-467
[24.]
O.M. Kon, J.B.G. Redhead, D. Gillen, J. Fothergill, J.A. Henry, D.M. Mitchell.
“Crack Lung” caused by an impure preparation.
Thorax, 51 (1996), pp. 959-960
[25.]
P.I. Oh, M.S. Balter.
Cocaine induced eosinophilic lung disease.
Thorax, 47 (1992), pp. 478-479
[26.]
P.V. Dicpinigaitis, J.G. Jones, M.M. Frymus, V.W. Folker.
Crack cocaine-induced syndromemimicking sarcoidosis.
Am J Med Sci, 317 (1999), pp. 416-418
[27.]
A.E. O’Donnell, J. Selig, M. Aravamuthan, M.S. Richardson.
Pulmonary complications associated with illicit drug use.
Chest, 108 (1995), pp. 460-463
[28.]
E. Anne, M.D. O’ Donnell.
HIV in illicit drug users: Clinics in Chest Medicine., 17 (December 1996),
[29.]
C. Hind.
Pulmonary complications of intravenous drug misuse.
Epidemiology and non-infective complications. Thorax, 45 (1990), pp. 891
[30.]
Kathleen A. Mccarrol MD, Myer H. Roszler MD.
Lung disorders due to drug abuse.
J Thorac Imaging, 6 (1991), pp. 30-35
[31.]
L.B. Thorne, K.A.J. Collins.
Speedballing with needle embolization: case Study and review of literature.
Forensis Sci, 43 (1998), pp. 1074-1164
[32.]
M.N. Kula Ylat, N. Barakat, R.N. Stephan, I. Gutierrez.
Embolization of illicit needle fragments.
J Emer Med, 11 (1993), pp. 403-408
[33.]
S. Hecht, M. Berger.
Right-sided endocarditis in intravenous drug users. Prognostic features in 102 episodes.
Ann Intern Med, 117 (1992), pp. 560
[34.]
M. Warnock, G. Ghahremani, C. Rattenbrg, et al.
Pulmonary complication of heroin intoxication. Aspiration pneumonia and diffuse bronchiectasis.
JAMA, 219 (1972), pp. 1051
[35.]
G. Weisbrod, M. Rahman, D. Chamberlain, Hermans.
Precocious emphysema in intravenous drug abusers.
J Thorax Imaging, 8 (1993), pp. 233
[36.]
T. Zorc, A. O’Donnell, R. Holt, et al.
Bilateral pyopneumotorax secondary to intravenous drug abuse.
Chest, 93 (1988), pp. 645
[37.]
D.R. Taylor, R. Poulton, T.E. Moffitt, et al.
The respiratory effects of cannabis dependence in young adults.
Addiction, (2000), pp. 1516-1518
[38.]
D.P. Tashkin, A.H. Coulson, V.A. Clark, et al.
Respiratory symptoms and lung function in habitual, heavy smokers of marijuana alone, smokers of marijuana and tabacco, smokers of tabacco alone, and nonsmokers.
Am Rev Resp Dis, 135 (1987), pp. 209-216
[39.]
D.P. Tashkin, M.S. Simmons, D. Sherrill, et al.
Heavy habitual marijuana smoking does not cause an accelerate decline in FEY, with age: a longitudinal study.
Am J Respir Crit Care Med, 155 (1997), pp. 141-148
[40.]
Sean P. Gaine MD FCCP, Lewis J. Rubin MD FCCP, James J. Kmetzo MD, Harold I. Palevsky MD FCCP, Thomas A. Traill MD.
Recreational Use of Aminorex and Pulmonary Hypertension.
Chest, 118 (2000), pp. 1496-1497
[41.]
Timothy E. Albertson MD PHD FCCP, F. William, M.S. Walby, Robert W. Derlet MD.
Stimulant-induced Pulmonary Toxicity.
Chest, 108 (1995), pp. 1140-1149
[42.]
E. Pisani.
AIDS into the 21-st century: some critical considerations.
Report Health Matters, 8 (2000 May), pp. 63-76
[43.]
K.A. Crandall.
The evolution of HIV, The Johns Hopkins University Press, (1999),
[44.]
M.S. Hirsch, J.W. Curran.
Human immunodeficiency viruses.
Virology,
[45.]
M. Essex.
Human immunodeficiency viruses in the developing world.
Adv Virus Res, 53 (1999), pp. 71-78
[46.]
CENTRO DE VIGILÂNCIA EPIDEMIOLÓGICA DE DOENÇAS TRANSMISSÍVEIS (CVEDT)/INSTITUTO NACIONAL DE SAUDE (TNSA) 2000 03-31.
[47.]
M.J. Rosen.
Epidemiology and risk of pulmonary disease.
Semin Respir Infect, 14 (1999), pp. 301-308
[48.]
Jeanne M. Wallace, I. Nellie, Hansen Lisa Lavange, Jeffrey Glassroth, Ben I. Browdy, Mark J. Rosien, Paul A. Kvale, T. Bonita, Mangura, Lee B. Reichman, Philip C. HopeWell.
Respiratory disease trends in Pulmonary complication of HIV infection Study Cohort.
Am J Resp Crit Care Med, 155 (1997), pp. 72-80
[50.]
M.J. Rosen.
Pneumonia in patients with HIV infection.
Med Clin North Am, 78 (1994), pp. 1067-1079
[51.]
D. Dreyfuss, K. Djedaini, C. Bidault-Lapomme, F. Coste.
Non traumatic acute anterior mediastinitis in two HIV positive heroin addicts.
Chest, 101 (1992), pp. 583
[52.]
Mark J. Rosen, Y.U. Lou, Paul A. Kvale, A. Vuaya Rao, Matthew C. Jordan, AlbertMiller, Jeffrey Glassroth, Lee B. Reichman, Jeanne M. Wallace, Philip C. Hopewell.
Pulmonary function test in HIV-infect patients without AIDS.
Am J Resp Crit Care Med, 152 (1995), pp. 738-745
[53.]
P.A. Kvale, M.J. Rosen, P.C. Hopewell, N. MarkWitz, N. Hansen, L.B. Reichn, J.M. Wallace, J. Glassroth, W. Fulkerson, Meiselman.
A decline in the pulmonary diffusing capacity does not indicate opportunistic lung disease in asymptomatic persons infected the human immunodeficiency virus. Pulmonary complication of HIV infection study group.
Am Rev Respir Dis, 148 (1993), pp. 390-395
[54.]
G. Moscato, R. Maserati, P. Marraccini, F. Caccamo, A. Dellabianca.
Bronchial reactivity to methacholine in HIV-infect without AIDS.
Chest, 103 (1993), pp. 796-799
[55.]
Merle A. Sande, Paul A. Volberding.
Medical Management of AIDS. Pub. Saunders, (1998),
[56.]
Jaime Pina.
A tuberculose na viragem do milénio, Lidel-Edicões Técnicas, Lda, (2000),
[57.]
Pina J, Diniz A, Gomes C, Enriques J, Mineiro A, Raim Undo P, Ravara S. Tuberculose e SIDA. Curso lnteractivo de Pneumologia.
Copyright © 2002. Sociedade Portuguesa de Pneumologia/SPP
Special content about COVID-19
- Hyperoxemia in invasively ventilated COVID–19 patients–Insights from the PRoVENT–COVID study
- Association between respiratory distress time and invasive mechanical ventilation in COVID-19 patients: A multicentre regional cohort study
- Assisted mobilisation in critical patients with COVID-19
- Two years of COVID-19: Trends in rehabilitation
Recommended
articles
articles
Pulmonol. 2024;30:254-64
Open access
This work is licensed under a Creative Commons Attribution 4.0 International License.
Publish in
Pulmonology
Pulmonology
- Home
- All contents
- Publish your article
- About the journal
- Metrics
- Open access
Article options